Congress Weighs Options to Control Opioid Copycats
WASHINGTON — Drug control experts urged Congress Tuesday to take quick action to prevent drugs created by clandestine chemists that mimic the effects of opioids from entering legal and illegal marketplaces.
They suggested that Congress turn a temporary order on the chemicals into a permanent prohibition by classifying them as Class 1 – or highly illegal — drugs, similar to heroin or cocaine.
“Congressional action would resolve this issue and permanently address the United States’ response to these deadly fentanyl-related substances,” said Amanda Liskamm, a Justice Department opioid enforcement attorney.
She spoke during a hearing of the House Judiciary Subcommittee on Crime, Terrorism and Homeland Security, which is considering legislation to prevent the spread of opioid synthetics.
The copycat drugs are commonly called fentanyl analogues, named for the powerful opioid painkiller Fentanyl. It is 100 times more potent than morphine as a painkiller but also more likely to lead to drug addiction and death from overdose.
The federal government’s year-old classification of fentanyl analogues as Class 1 drugs is set to expire Feb. 6.
So far, Congress has reacted with only temporary legislation to avoid interfering with research into antidotes for drug overdoses. It also was looking for a better definition of the broad class of fentanyl analogues.
Liskamm said the proliferation of fentanyl analogues creates significant risk for the public if there is no legislation that clamps down on the drug but still allows research to continue.
“Unfortunately, clandestine chemists have with relative ease created new synthetic variations of fentanyl by introducing minor structural modifications, resulting in new, non-controlled fentanyl-related substances,” Liskamm said in her testimony Tuesday. “These substances are specifically engineered to skirt U.S. law.”
The U.S. Centers for Disease Control and Prevention has reported fentanyl and chemical copycats caused 41 percent of the 70,200 U.S. drug overdoses in 2017.
The Trump administration turned over its proposal for new legislation to Congress Tuesday. It was discussed during the House hearing.
The proposal would give the Drug Enforcement Administration (DEA) discretion to decide which fentanyl analogues should be permanently classified as Class 1 drugs. The measure is supposed to make it easier for law enforcement agencies to prosecute anyone who tries to sell opioid’s chemical substitutes.
The proposal also would ease some rules on fentanyl analogue research.
The proposal was developed by the Justice Department and U.S. Health and Human Services Department, both of which sent witnesses to the congressional hearing.
Other parts of the Trump administration proposal would allow the Department of Health and Human Services to remove analogues from Schedule 1 classification if they have medical merit but a low potential for abuse. Some registration requirements for researchers would be streamlined.
The Trump administration proposal is essentially the same as a Republican bill pending in Congress. A vote in the House is expected as soon as this week.
The Senate passed legislation on fentanyl analogues this month but it only extends the temporary classification as a Class1 drug.
Some Democrats expressed concern during the House hearing that the bill could lead to widespread prosecutions of low-level drug offenders who are selling only weak versions of the fentanyl analogues.
One of them was U.S. Rep. Karen Bass, a California Democrat who chairs the subcommittee on crime, terrorism and homeland security.
“Rather than relying solely on incarceration, we need to also focus significantly on treatment,” Bass said. “Under current federal sentencing guidelines, many defendants who are not high level traffickers may be unnecessarily subjected to mandatory minimums that in fact become life sentences. I want to make sure that we don’t repeat what we’ve done in past epidemics, which is the over-criminalization of an addiction.”
In The News
In The News
The National Governors Association is joining with the National Guard Association of the United States to oppose the Department of Defense’s planned reprogramming, which would cut nearly $1.7 billion from the National Guard and Reserve. At the request of the nation’s governors, Congress, on a bipartisan... Read More
The Republican National Committee and Michigan Republican Party last week filed a motion to intervene in a lawsuit over the right of organizers to participate in elections. The underlying lawsuit was filed by Priorities USA, a Democratic super PAC, in November. It challenges Michigan state laws... Read More
In a blistering dissent issued late Friday night, Supreme Court Justice Sonya Sotomayor chastised the Trump administration for repeatedly asking the high court to allow controversial policies to go into effect on an emergency basis. At the same time, and in a rare instance for the... Read More
MANAGUA, Nicaragua — The board of directors of Nicaragua’s oldest newspaper sat down in January to discuss the future. It looked bleak. Like many print publications in the digital age, La Prensa had been struggling for years amid declining advertising revenue. A recent economic recession had... Read More
Finance chiefs from the world’s 20 largest economies haggled over climate change and proposals for a global tax regime as they tried to draft a joint communique at a conference overshadowed by a viral outbreak that’s shaken the global economy. Delegates at the G-20 meeting in... Read More
When President Trump ticks off his accomplishments since taking office, he frequently mentions his aggressive makeover of a key sector of the federal judiciary — the circuit courts of appeal, where he has appointed 51 judges to lifetime jobs in three years. In few places has... Read More